Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection

Virology

Volumn 223, Issue 1, 1996, Pages 103-112

  Yao, Qizhi ^a   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE; VIRUS FUSION PROTEIN;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CELL FUSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PARAINFLUENZA VIRUS; PRIORITY JOURNAL;

EID: 0030245704     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0459     Document Type: Article

References (57)

1. Bousse, T., Takimoto, T., Gorman, W. L., and Portner, A. (1994). Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type 1 and Sendai virus important for membrane fusion. Virology 204, 506-514.
2. Buckland, R., and Wild, F. (1989). Leucine zipper motif extends. Nature 338, 547.
3. Buckland, R., Malvoisin, E., Beauverger, P., and Wild, F. (1992). A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73, 1703-1707.
4. Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1994). Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37-43.
5. Carr, C. M., and Kim, P. S. (1993). A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73, 823-832.
6. Cattaneo, R., and Rose, J. K. (1993). Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J. Virol. 67, 1493-1502.
7. Chambers, P., Pringle, C. R., and Easton, J. J. (1990). Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71, 3075-3080.
8. Chen, S.-L., Lee, C.-N., Lee, W.-R., McIntosh, K., and Lee, T.-H. (1993). Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67, 3615-3619.
9. Choppin, P. W., and Compans, R. W. (1975). Reproduction of paramyxoviruses. In "Comprehensive Virology" (H. Fraenkel-Conrat and R. R. Wagner, Eds.), Vol. 4, pp. 95-178. Plenum, New York.
10. Choppin, P. W., and Scheid, A. (1980). The role of viral glycoproteins in adsorption, penetration and pathogenicity of viruses. Rev. Infect. Dis. 2, 40-61.
11. Deng, R., Wang, Z., Mirza, A. M., and Iorio, R. M. (1995). Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 209, 457-469.
12. Doms, R. W., White, J. M., Boulay, F., and Helenius, A. (1990). Influenza virus hemagglutinin and membrane fusion. In "Cellular Membrane Fusion: Fundamental Mechanisms and Applications of Membrane Fusion Techniques" (J. W. D. Hoekstra, Ed.). Dekker, New York.
13. Dubay, J. W., Roberts, S. J., Brody, B., and Hunter, E. (1992). Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66, 4748-4756.
14. Gittman, A. G., and Loyter, A. (1984). Construction of fusogenic vesicles bearing specific antibodies: targeting of reconstituted Sendai virus envelopes towards neuraminidase-treated human erythrocytes. J. Biol. Chem. 259, 9813-9820.
15. Heath, T. D., Martin, F. J., and Macher, B. A. (1983). Association of ganglioside-protein conjugates into cell and Sendai virus: requirement for the HN subunit in viral fusion. Exp. Cell Res. 149, 163-175.
16. Heminway, B. H., Yu, Y., and Galinski, M. S. (1994). Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res. 31, 1-16.
17. Homma, M., and Ohuchi, M. (1973). Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural differences of Sendai viruses grown in eggs and tissue culture cells. J. Virol. 12, 1457-1463.
18. Horvath, C. M., Paterson, R. G., Shaughnessy, M. A., Wood, R., and Lamb, R. A. (1992). Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J. Virol. 66, 4564-4569.
19. Hsu, M.-C., Scheid, A., and Compans, R. W. (1979). Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology 95, 476-491.
20. Hsu, M.-C., Scheid, A., and Choppin, P. W. (1981). Activation of the Sendai virus fusion protein (F) involved a conformational change with exposure of a new hydrophobic region. J Biol. Chem. 256, 3557-3563.
21. Hsu, M.-C., Scheid, A., and Choppin, P. W. (1982). Enhancement of membrane-fusion activity of Sendai virus by exposure of the virus to basic pH is correlated with a conformational change in the fusion protein. Proc. Natl. Acad. Sci. USA 79, 5862-5866.
22. Hu, X., Ray, R., and Compans, R. W. (1992). Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol. 66, 1528-1534.
23. Jang, S., Lin, K., Strick, N., and Neurath, A. R. (1993a). HIV-1 inhibition by a peptide. Nature 365, 113. [Letter]
24. Jang, S., Lin, K., Strick, N., and Neurath, A. R. (1993b). Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41. Biochem. Biophys. Res. Commun. 195, 533-538.
25. Kemble, G. W., Danieli, T., and White, J. M. (1994). Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 76, 383-391.
26. Lamb, R. A. (1993). Paramyxovirus fusion: A hypothesis for changes. Virology 197, 1-11.
27. Lambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G., and Perreway, S. R., Jr. (1996). Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93, 2186-2191.
28. Malvoisin, E., and Wild, T. F. (1993). Measles virus glycoproteins: studies on the structure and interaction of the hemagglutinin and fusion proteins. J. Gen. Virol. 74, 2365-2372.
29. Merz, D. C., and Wolinsky, J. S. (1983). Conversion of nonfusing mumps virus infections by selective proteolysis of the HN glycoprotein. Virology 131, 328-340.
30. Miura, N., Uchida, T., and Okada, Y. (1982). HVJ(Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutinin activity of HVJ. Exp. Cell Res. 141, 409-420.
31. Morrison, T. G., and Portner. (1991). Structure, function, and intracellular processing of the glycoprotein of Paramyxoviridae. In "The Paramyxoviruses" (D. W. Kingsbury, Ed.), pp. 347-382. Plenum, New York.
32. Nussbaum, O., Sakai, N., and Loyter, A. (1984). Membrane bound antiviral antibodies as receptors for Sendai virions in receptor depleted erythrocytes. Virology 138, 185-197.
33. O'Shea, E., Rutkowski, R., and Kim, P. (1989). Evidence that the leucine zipper is a coiled-coil. Science 243, 538-543.
34. Paterson, R. G., Shaughnessy, M. S., and Lamb, R. A. (1989). Analysis of the relationship between cleavability of paramyxovirus fusion protein and length of the connecting peptide. J. Virol. 63, 1293-1301.
35. Portner, A., Scroggs, R. A., and Metzger, D. W. (1987). Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology 156, 61-68.
36. Rapaport, D., Ovadia, M., and Shai, Y. (1995). A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai Virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J. 14, 5524-5531.
37. Reitter, J. N., Sergel, T., and Morrison, T. G. (1995). Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69, 5995-6004.
38. Ruigrok, R. W., Aitken, A., Calder, L. J., Martin,S. R., Skehel, J. J., Wharton, S. A., Weis, W., and Wiley, D. C. (1988). Studies on the structure of the influenza virus HA at the pH of membrane fusion. J. Gen. Virol. 69, 2785-2795.
39. Scheid, A., and Choppin, P. W. (1974). Identification and biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57, 475-490.
40. Sergel, T., McGinnes, L. W., Peeples, M. E., and Morrison, T. G. (1993). The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 193, 717-726.
41. Sergel, T. G., McQuain, C., and Morrison, T. G. (1994). Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68, 7654-7658.
42. Shibuta, H., Nozawa, A., Shioda, T., and Kanda, T. (1983). Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus. Infect. Immun. 41, 780-788.
43. Stegmann, T., Booy, F. P., and Wilschut, J. (1987). Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin. J. Biol. Chem. 262, 17744-17749.
44. Tanabayashi, K., and Compans, R. W. (1996). Functional interaction of paramyxovirus glycoproteins: Identification of a domain in Sendai virus HN which promotes cell fusion, J. Virol., in press.
45. Thompson, S. D., and Porter, A. (1987). Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature sensitive mutants. Virology 160, 1-8.
46. Tsurudome, M., Hamada, A., Hishiyama, M., and Ito, Y. (1986). Monoclonal antibodies against the glycoproteins of mumps virus: Fusion inhibition by anti-HN monoclonal antibody. J. Gen. Virol. 67, 2259-2265.
47. Tsurudome, M., Kawano, M., Yuasa, T., Tabata, N., Nishino, M., Komada, H., and Ito, Y. (1995). Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion. Virology 213, 190-203.
48. Waxham, M. N., and Wolinsky, J. S. (1986). A fusing mumps virus variant selected from a nonfusing parent with the neuraminidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 151, 286-295.
49. Welkos, S., and O'Brien, A. (1994). Determination of median lethal and infectious doses in animal model systems. Methods Enzymol. 235, 29-39.
50. Wharton, S. A. (1987). The role of influenza virus haemagglutinin in membrane fusion. Microbiol. Sci. 4, 119-124.
51. White, J. M., and Wilson, I. A. (1987). Anti-peptide antibodies detect steps in a protein conformational change: Low pH activation of the influenza virus HA. J. Cell Biol. 105, 2887-2896.
52. Wild, C. T., Oas, T., McDanal, C. B., Bolognesi, D., and Matthews, T. J. (1992). A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89, 10537-10541.
53. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., and Matthews, T. J. (1994a). Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770-9774.
54. Wild, C. T., Greenwell, T. K., Shugars, D., Rimsky-Clarke, L., and Matthews, T. J. (1995). The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retroviruses 11, 323-325.
55. Wild, T. F., Fayolle, J., Beauverger, P., and Buckland, R. (1994b). Measles virus fusion: Role of the cysteine-rich region of the fusion glycoprotein. J. Virol. 68, 7546-7548.
56. Wilson, I. A., Skehel, J. J., and Wiley, D. C. (1981). Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (London) 289, 366-373.
57. Yao, Q., and Compans, R. W. (1995). Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins. J. Virol. 69, 7045-7053.